Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis (Q34631127)

3 August 2017

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis (English)

1 reference

3 August 2017

0 references

0 references

Vito Di Lernia

1

1 reference

3 August 2017

Laura Tasin

2

1 reference

3 August 2017

Riccardo Pellicano

3

1 reference

3 August 2017

Giuseppe Zumiani

4

1 reference

3 August 2017

Giuseppe Albertini

5

1 reference

3 August 2017

24 July 2011

1 reference

Journal of Dermatological Treatment

3 August 2017

1 reference

3 August 2017

23

1 reference

3 August 2017

404-409

1 reference

3 August 2017

6

1 reference

The long-term efficacy and safety of new biological therapies for psoriasis

3 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Prognostic factor analysis for plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.593489

10.3109/09546634.2011.593489

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference